Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-097519
Filing Date
2024-11-13
Accepted
2024-11-13 16:42:05
Documents
60
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0220287-10q_adial.htm   iXBRL 10-Q 592889
2 CERTIFICAION ea022028701ex31-1_adial.htm EX-31.1 7805
3 CERTIFICAION ea022028701ex31-2_adial.htm EX-31.2 7981
4 CERTIFICAION ea022028701ex32-1_adial.htm EX-32.1 3694
5 CERTIFICAION ea022028701ex32-2_adial.htm EX-32.2 3662
  Complete submission text file 0001213900-24-097519.txt   4335703

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adil-20240930.xsd EX-101.SCH 39709
7 XBRL CALCULATION FILE adil-20240930_cal.xml EX-101.CAL 35083
8 XBRL DEFINITION FILE adil-20240930_def.xml EX-101.DEF 217310
9 XBRL LABEL FILE adil-20240930_lab.xml EX-101.LAB 394014
10 XBRL PRESENTATION FILE adil-20240930_pre.xml EX-101.PRE 222354
62 EXTRACTED XBRL INSTANCE DOCUMENT ea0220287-10q_adial_htm.xml XML 416730
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

EIN.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38323 | Film No.: 241455113
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)